Literature DB >> 2533664

Characteristics of Ca2(+)-stimulated ATPase in rat heart sarcolemma in the presence of dithiothreitol and alamethicin.

E K Seppet1, N S Dhalla.   

Abstract

We have studied the activities of Ca2(+)-stimulated ATPase in rat heart sarcolemma upon modulating the redox state of membrane thiol groups with dithiothreitol (DTT). The suitability of alamethicin to unmask the latent activity of this enzyme was also investigated. The Ca2(+)-stimulated ATPase in sarcolemma exhibited two activation sites--one with low affinity (Km = 0.70 +/- 0.2 mM; Vmax = 10.0 +/- 2.2 mumol Pi/mg/h) and the other with high affinity (Km = 0.16 +/- 0.7 mM; Vmax = 4.6 +/- 0.8 mumol Pi/mg/h) for Mg2+ ATP. Alamethicin at a ratio of 1:1 with the sarcolemmal protein caused a 3-fold activation of Ca2(+)-stimulated ATPase without affecting its sensitivity to Ca2+ or Mg2+ ATP. Treatment of sarcolemma with deoxycholate or sodium dodecyl sulfate resulted in a total loss of the enzyme activity; high concentrations of alamethicin also showed a detergent-like action on the sarcolemmal vesicles. DTT at 5-10 mM concentrations caused a 4-5 fold activation of Ca2(+)-stimulated ATPase in sarcolemma and this effect was observed to be dependent on the concentration of Mg2+ ATP. DTT increased the affinity of the enzyme to Mg2+ ATP at the high affinit site and enhanced the Vmax at the low affinity site in addition to increasing the sensitivity of Ca2(+)-stimulated ATPase to Ca2+. DTT protected the Ca2(+)-stimulated ATPase against deterioration by detergents and restored the enzyme activity after treatment with N-ethylmaleimide. The mechanism of action of DTT on Ca2(+)-stimulated ATPase may involve the reduction of essential thiols at the active site of the enzyme or its interaction with specific DTT-dependent inhibitor protein. No changes in the sensitivity of sarcolemmal Ca2(+)-stimulated ATPase to orthovanadate was evident in the absence or presence of DTT and alamethicin. The results suggest the use of both DTT and alamethicin for the determination of Ca2(+)-stimulated ATPase activity in sarcolemmal preparations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2533664     DOI: 10.1007/bf00228089

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  24 in total

1.  A microcolorimetric method for the determination of inorganic phosphorus.

Authors:  H H TAUSSKY; E SHORR
Journal:  J Biol Chem       Date:  1953-06       Impact factor: 5.157

2.  Monovalent cation stimulation of Ca2+ uptake by cardiac membrane vesicles.

Authors:  L R Jones; H R Besch; A M Watanabe
Journal:  J Biol Chem       Date:  1977-05-25       Impact factor: 5.157

3.  Parallel unmasking of latent adenylate cyclase and (Na+,K+)-ATPase activities in cardiac sarcolemmal vesicles. A new use of the channel-forming ionophore Alamethicin.

Authors:  H R Besch; L R Jones; J W Fleming; A M Watanabe
Journal:  J Biol Chem       Date:  1977-11-25       Impact factor: 5.157

4.  Effects of potassium on vanadate inhibition of sarcoplasmic reticulum Ca2+-ATPase from dog cardiac and rabbit skeletal muscle.

Authors:  T Wang; L I Tsai; R J Solaro; A O Grassi de Gende; A Schwartz
Journal:  Biochem Biophys Res Commun       Date:  1979-11-14       Impact factor: 3.575

5.  Thyroxine and propylthiouracil effects on alpha- and beta-adrenergic receptor number, ATPase activities, and sialic acid content of rat cardiac membrane vesicles.

Authors:  M M McConnaughey; L R Jones; A M Watanabe; H R Besch; L T Williams; R J Lefkowitz
Journal:  J Cardiovasc Pharmacol       Date:  1979 Nov-Dec       Impact factor: 3.105

6.  Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands.

Authors:  A Fabiato
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

Review 7.  Transport adenosine triphosphatases: properties and functions.

Authors:  F Schuurmans Stekhoven; S L Bonting
Journal:  Physiol Rev       Date:  1981-01       Impact factor: 37.312

8.  Rabbit myocardial membrane Ca2+-adenosine triphosphatase activity: stimulation in vitro by thyroid hormone.

Authors:  A Rudinger; K M Mylotte; P J Davis; F B Davis; S D Blas
Journal:  Arch Biochem Biophys       Date:  1984-02-15       Impact factor: 4.013

9.  Reactive sulfhydryl groups of sarcoplasmic reticulum ATPase. III. Identification of cysteine residues whose modification with N-ethylmaleimide leads to loss of the Ca2+-transporting activity.

Authors:  M Kawakita; T Yamashita
Journal:  J Biochem       Date:  1987-07       Impact factor: 3.387

10.  Intact vesicles of canine cardiac sarcolemma: evidence from vectorial properties of Na+, K+-ATPase.

Authors:  H R Besch; L R Jones; A M Watanabe
Journal:  Circ Res       Date:  1976-10       Impact factor: 17.367

View more
  5 in total

1.  Bilayer lipid composition modulates the activity of dermaseptins, polycationic antimicrobial peptides.

Authors:  Hervé Duclohier
Journal:  Eur Biophys J       Date:  2006-02-14       Impact factor: 1.733

2.  Cardiac sarcolemmal Na(+)-Ca2+ exchange and Na(+)-K+ ATPase activities and gene expression in alloxan-induced diabetes in rats.

Authors:  L Golfman; I M Dixon; N Takeda; A Lukas; K Dakshinamurti; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

3.  Alterations in G-proteins in congestive heart failure in cardiomyopathic (UM-X7.1) hamsters.

Authors:  R Sethi; N Bector; N Takeda; M Nagano; G Jasmin; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1994-11-23       Impact factor: 3.396

4.  Role of sulfhydryl groups in phospholipid methylation reactions of cardiac sarcolemma.

Authors:  R Vetter; J Dai; N Mesaeli; V Panagia; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1991-04-24       Impact factor: 3.396

5.  Characterization of adenylyl cyclase in heart sarcolemma in the absence or presence of alamethicin.

Authors:  R Sethi; K S Dhalla; K R Shah; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.